Search research articles
Contact Us
Filters
Showing results (581-590 of 613) with videos related to
Page
of 62
Sort By:
The New England Journal of Medicine
|
April 21, 2015
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Michael A Postow, Jason Chesney, Anna C Pavlick, et al.
BMC Pediatrics
|
June 10, 2026
Genotypic and phenotypic features of 23 Egyptian patients with tuberous sclerosis complex
Amr A Othman, Abdelrahim A Sadek, Mohammed A Aladawy, et al.
Cancer
|
August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study
Mohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naive Advanced Melanoma
Antoni Ribas, Mohammed M Milhem, Christopher J Hoimes, et al.
Melanoma Research
|
July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma
Alexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
JTO Clinical and Research Reports
|
December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Cancer Medicine
|
May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis
Robert C Chick, Mark B Faries, Diane F Hale, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
European Journal of Immunology
|
December 18, 2025
Diurnally-Regulated Corticosterone and Melatonin Inversely Control Endotoxin-Induced Acute Immune Responses
Montaser Haddad, Sebastien Trzebanski, Ramon Bossardi Ramos, et al.
Nature Biotechnology
|
March 4, 2022
Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells
Diego Balboa, Tom Barsby, Väinö Lithovius, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 613) with videos related to
Sort By:
Page
of 62
The New England Journal of Medicine
|
April 21, 2015
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Michael A Postow, Jason Chesney, Anna C Pavlick, et al.
BMC Pediatrics
|
June 10, 2026
Genotypic and phenotypic features of 23 Egyptian patients with tuberous sclerosis complex
Amr A Othman, Abdelrahim A Sadek, Mohammed A Aladawy, et al.
Cancer
|
August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study
Mohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naive Advanced Melanoma
Antoni Ribas, Mohammed M Milhem, Christopher J Hoimes, et al.
Melanoma Research
|
July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma
Alexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
JTO Clinical and Research Reports
|
December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Cancer Medicine
|
May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis
Robert C Chick, Mark B Faries, Diane F Hale, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
European Journal of Immunology
|
December 18, 2025
Diurnally-Regulated Corticosterone and Melatonin Inversely Control Endotoxin-Induced Acute Immune Responses
Montaser Haddad, Sebastien Trzebanski, Ramon Bossardi Ramos, et al.
Nature Biotechnology
|
March 4, 2022
Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells
Diego Balboa, Tom Barsby, Väinö Lithovius, et al.
Page
of 62